In This Section

Newsroom

  • Dr. Grace Ma

    Philadelphia Inquirer Interviews Dr. Grace Ma for Article about Health Disparities and Barriers to Health Care Faced by Asian-Americans

    Grace X. Ma, PhD, Associate Dean for Health Disparities, Founding Director of the Center for Asian Health and Laura H. Carnell Professor in the Department of Urban Health and Population Science at the Lewis Katz School of Medicine at Temple University, was interviewed for an article in the Philadelphia Inquirer about health disparities and barriers to health care faced by Asian-Americans. Dr. Ma was recently awarded a five-year, $4 million grant from the National Institute on Minority Health and Health Disparities of the National Institutes of Health (NIH). The grant is the first of its kind to support research that addresses the impacts of structural racism and discrimination on liver cancer and liver disease in high-risk Asian-Americans. Specifically, the research will focus on three ethnic groups – Chinese-, Korean-, and Vietnamese-Americans.

  • Kamel Khalili, PhD looking into a microscope

    First Individual Treated with CRISPR-Based HIV Therapy, a Breakthrough Treatment Pioneered by Researchers at Lewis Katz School of Medicine at Temple University and Developed by Excision BioTherapeutics

    In a major milestone in the search for a cure for HIV/AIDS, a breakthrough gene-editing therapy for human immunodeficiency virus type 1 (HIV) infection now being tested in clinical trials has been administered to a human with HIV for the first time.

  • Biomedical Science Program students at Temple University’s Lewis Katz School of Medicine with their award certificates following the Annual Dawn Marks Research Day

    21st Annual Dawn Marks Research Day: Presenting - and Communicating -- Biomedical Research

    For Biomedical Science Program students at Temple University’s Lewis Katz School of Medicine, few things signify the start of a new academic year quite like the Annual Dawn Marks Research Day.

  • Riyaz Bashir, MD, FACC, in an operating room, holding an endovascular catheter

    Endovascular Catheter Developed at the Lewis Katz School of Medicine at Temple University Shows Unprecedented Ability to Treat Pulmonary Artery Obstruction

    A device known as the BASHIR™ Endovascular Catheter (THROMBOLEX, Inc.) significantly reduces the size of blood clots lodged in the pulmonary arteries, leading to improvement in heart function in patients with pulmonary embolism, researchers from the Lewis Katz School of Medicine at Temple University announced in a Late-Breaking Innovation session at the 2022 Transcatheter Cardiovascular Therapeutics (TCT) conference in Boston.

  • Riyaz Bashir, MD, FACC, in an operating room, holding an endovascular catheter

    Multiple Media Outlets Highlight Breakthrough News about the BASHIR™ Endovascular Catheter

    Researchers at the Lewis Katz School of Medicine at Temple University announced in a Late-Breaking Innovation Session at the 2022 Transcatheter Cardiovascular Therapeutics conference that the BASHIR™ Endovascular Catheter significantly reduces the size of blood clots lodged in pulmonary arteries, leading to improvement in heart function in patients with pulmonary embolism. The breakthrough is also described in a report published in the Journal of the American College of Cardiology: Cardiovascular Interventions. Riyaz Bashir, MD, FACC, Professor of Medicine at the Katz School of Medicine and Director of Vascular and Endovascular Medicine at Temple University Hospital, is the co-inventor of the catheter. Dr. Bashir conducted a video interview with Clinical Trial Results about the catheter and the RESCUE trial, a clinical study designed to evaluate the safety and efficacy of the catheter as a novel therapy for pulmonary embolism. The American College of Cardiology, Scienmag and the Science Times also highlighted the news. Parth Rali, MD, Associate Professor of Thoracic Medicine and Surgery at the Lewis Katz School of Medicine and Director of the Temple University Health System Pulmonary Embolism Response Team (PERT), is the local principal investigator on the RESCUE trial. Vladimir Lakhter, DO, Assistant Professor of Medicine at the Lewis Katz School of Medicine and an interventional cardiologist, is also involved in the RESCUE trial.

  • Daniel A. Salerno, MD, MS

    Dr. Daniel Salerno and Patient Share Diagnosis and Treatment for Mycobacterium Avium Complex in Philadelphia Inquirer’s ‘Medical Mystery’ Feature

    Daniel A. Salerno, MD, MS, Associate Professor of Thoracic Medicine and Surgery at the Lewis Katz School of Medicine at Temple University and Director of Critical Care Services in the Respiratory Intensive Care Unit at Temple University Hospital, and a patient shared the story of her diagnosis and treatment for mycobacterium avium complex (MAC) in the Philadelphia Inquirer’s “Medical Mystery” feature.

  • Carolyn Y. Fang, PhD and Jean Lee, MD, FACP

    Dismantling Discrimination in Healthcare: Asian American and Pacific Islander Heritage Month Award Winners

    Nine individuals associated with the Lewis Katz School of Medicine and Temple University Health System have been honored with Health Equity Leadership and Social Justice Awards for their efforts to raise awareness of the discrimination faced by many Asian Americans and Pacific Islanders -- and for their work to dismantle the barriers to healthcare that result from it.

  • Jamie Garfield, MD

    Lewis Katz School of Medicine’s Efforts Featured in Philadelphia Inquirer Article about Standardized Patients in Medical Education

    A Philadelphia Inquirer article focused on how area medical schools, including the Lewis Katz School of Medicine at Temple University, are utilizing standardized patients in medical education. The Inquirer article highlighted a new grant that Temple received to develop an educational program to promote sensitive and equitable care for transgender and nonbinary people in Philadelphia. Jamie Garfield, MD, Professor of Thoracic Medicine and Surgery and Core Clinical Educator at the Katz School of Medicine and Director of Quality and Improvement and Patient Safety, Core Clinical Faculty, Internal Medicine Residency, at Temple University Hospital, is the principal investigator on the grant and spoke with the Inquirer. Denise Salerno, MD, FAAP, Associate Dean of Undergraduate Medical Education and Longitudinal Curricular Threads and Professor of Clinical Pediatrics at the Katz School of Medicine, and David A. Wald, DO, FACOEP, Interim Assistant Dean of Phase 3 and Assistant Dean of Clinical Simulation and Professor of Emergency Medicine at the Katz School of Medicine, were also interviewed.

Pages